Allmed Medical Products Co.,Ltd (SHE:002950)
China
· Delayed Price · Currency is CNY 8.38
-0.01 (-0.12%)
May 9, 2025, 2:45 PM CST
SHE:002950 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Net Income | 368.8 | 110.4 | 406.79 | 431.21 | 1,158 | Upgrade
|
| Depreciation & Amortization | 229.01 | 224.54 | 193.2 | 147.21 | 142.22 | Upgrade
|
| Other Amortization | 3.28 | 5.32 | 1.56 | 0.72 | 0.39 | Upgrade
|
| Loss (Gain) From Sale of Assets | -28.79 | 0.07 | -3.5 | -1.94 | -26.34 | Upgrade
|
| Asset Writedown & Restructuring Costs | 57.24 | -0.5 | 23.24 | 4.18 | 0.08 | Upgrade
|
| Loss (Gain) From Sale of Investments | 1.37 | 6.88 | 160.19 | -41.93 | -44.61 | Upgrade
|
| Provision & Write-off of Bad Debts | - | -0.31 | 1.7 | 3.18 | 1.35 | Upgrade
|
| Other Operating Activities | 11.44 | 143.9 | 173.98 | -15.11 | -18.34 | Upgrade
|
| Change in Accounts Receivable | -52.27 | 157.56 | -18.06 | 75.81 | 64.96 | Upgrade
|
| Change in Inventory | 151.35 | 71.09 | -37.14 | -143.41 | 18.49 | Upgrade
|
| Change in Accounts Payable | -53.16 | -244.71 | 162.03 | -111.76 | 84.37 | Upgrade
|
| Operating Cash Flow | 711.64 | 423.5 | 1,150 | 374.85 | 1,437 | Upgrade
|
| Operating Cash Flow Growth | 68.04% | -63.17% | 206.71% | -73.91% | 426.02% | Upgrade
|
| Capital Expenditures | -157 | -286.48 | -398.05 | -290.7 | -243.28 | Upgrade
|
| Sale of Property, Plant & Equipment | 9.01 | 0.77 | 3.64 | 7.14 | 85.76 | Upgrade
|
| Cash Acquisitions | - | - | -99.07 | -90.83 | - | Upgrade
|
| Investment in Securities | -1.27 | 139.45 | -475.05 | -98.84 | -620.73 | Upgrade
|
| Other Investing Activities | 4.6 | -69.21 | -1.99 | 0.11 | 33.43 | Upgrade
|
| Investing Cash Flow | -144.66 | -215.46 | -970.52 | -473.12 | -744.82 | Upgrade
|
| Short-Term Debt Issued | - | 180 | 381.91 | - | - | Upgrade
|
| Long-Term Debt Issued | 616.06 | 1,362 | 2,526 | 3,228 | 1,538 | Upgrade
|
| Total Debt Issued | 616.06 | 1,542 | 2,908 | 3,228 | 1,538 | Upgrade
|
| Short-Term Debt Repaid | - | -300.75 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -868.68 | -1,525 | -2,976 | -3,184 | -914.52 | Upgrade
|
| Total Debt Repaid | -868.68 | -1,826 | -2,976 | -3,184 | -914.52 | Upgrade
|
| Net Debt Issued (Repaid) | -252.62 | -283.52 | -67.51 | 44.41 | 623.19 | Upgrade
|
| Issuance of Common Stock | 0.6 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -44.11 | -65.21 | -163.9 | -577.16 | -266.5 | Upgrade
|
| Other Financing Activities | -94.03 | 19.92 | -5 | -20 | 2 | Upgrade
|
| Financing Cash Flow | -390.15 | -328.81 | -236.41 | -552.75 | 358.69 | Upgrade
|
| Foreign Exchange Rate Adjustments | 13.85 | 7.55 | -102.64 | 11.93 | 8.7 | Upgrade
|
| Net Cash Flow | 190.68 | -113.21 | -159.85 | -639.08 | 1,059 | Upgrade
|
| Free Cash Flow | 554.64 | 137.02 | 751.68 | 84.16 | 1,193 | Upgrade
|
| Free Cash Flow Growth | 304.78% | -81.77% | 793.19% | -92.95% | 2840.91% | Upgrade
|
| Free Cash Flow Margin | 16.68% | 4.97% | 17.85% | 2.88% | 31.12% | Upgrade
|
| Free Cash Flow Per Share | 0.89 | 0.22 | 1.19 | 0.13 | 1.89 | Upgrade
|
| Cash Income Tax Paid | -133.35 | -10.34 | -94.58 | -5.2 | -129.72 | Upgrade
|
| Levered Free Cash Flow | 429.76 | -367.43 | 996.96 | -70.89 | 914.36 | Upgrade
|
| Unlevered Free Cash Flow | 429.76 | -347.51 | 1,019 | -60.15 | 925.39 | Upgrade
|
| Change in Net Working Capital | -47.5 | 403.82 | -712.29 | 159.67 | -276.37 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.